Searched for
DRUG PLANTING CASE
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsGiven the state of the market these days, it would be wise to be selective. Not only in terms of stocks, but also in terms of sectors. For ...- US DOJ closes criminal probe into Abbott over baby formula plant: ReportThe US Justice Department has reportedly ended its criminal investigation into Abbott Laboratories concerning its baby formula plant, which...
- Cannabis-derived aroma compounds show surprising potential to relieve chronic pain in fibromyalgia and post-surgical models, shows researchResearchers from the University of Arizona have discovered that cannabis terpenes, the compounds responsible for the plant's distinct aroma...
- How a pressure cooker's smell exposed a ganja dealer during Kerala Police raid, watch the viral videoPolice in Thrissur, Kerala, arrested a man after a drug raid. He attempted to hide ganja inside a pressure cooker filled with rice. The unu...
- In the 1930s, rubber factory workers drank alcohol and suddenly felt sick. It wasn't just a workplace illness, it led to the discovery of Antabuse, helping millions quit drinkingAn accidental discovery in a rubber factory in the 1930s revealed that workers exposed to tetraethylthiuram disulfide experienced severe re...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
- Trump-Xi summit yields trade breakthrough as US, China agree to cut leviesChina and the United States have agreed to reduce tariffs on certain goods. This move aims to boost trade between the two nations, particul...
- Researchers develop sustainable method to boost active vitamin B12 in SpirulinaA scientific breakthrough offers a new way to produce vitamin B12. Researchers are using managed light on Spirulina, a blue-green algae. Th...
- Compliance squeeze, global scrutiny redefine India’s $30 billion pharma export playbookAs global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.
- Hyderabad laid-off techie turns 'ganja engineer' on terrace; 17 plants that could yield 10 kg seizedExcise officials in Hyderabad arrested a former software engineer for cultivating cannabis plants on his terrace. Investigators linked the ...
- Manipur: Violence after drugs seizure; 18 injured, vehicles set on fireThe violence erupted following the seizure of a large quantity of drugs from a suspected drug peddler at the Imphal airport.
- Trump pushes pharma tariffs, but exemptions limit impactThe United States has introduced tariffs on branded drug imports. However, many exemptions will limit their effect. Companies investing in ...
- SC rejects former IPS officer Sanjiv Bhatt's plea seeking suspension of sentence in 1996 drug seizure caseThe Supreme Court has denied former IPS officer Sanjiv Bhatt's request to halt his 20-year prison sentence. This sentence stems from a 1996...
- Scientists produce cancer drug from common lab plantStanford scientists have used a common laboratory plant to produce a widely used cancer fighting drug - previously only available from an e...
- Ranbaxy's Toansa plant under Indian drug regulator's watch tooIndia’s drug regulator has ordered Ranbaxy to furnish a comprehensive explanation for the violation of manufacturing practices at its Toans...
- Drug companies may have to disclose actions taken by international drug regulatorsIndian regulators' disconnect with global counterparts prevents access to inspection notification or to their findings.
- Drug Controller General of India to inspect bulk drug plants exporting to EUDCGI is readying a plan to check if domestic bulk drug facilities that export to the European Union comply with WHO-prescribed norms.
- After Ranbaxy, FDA finds gaps at CiplaThe US Food and Drug Administration (FDA) has found nine deviations in Indian drug maker Cipla’s manufacturing process during a recent insp...
Load More
